Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Peadiatric And Adult Study Population
Condition: Lyme Borreliosis Interventions: Biological: VLA15; Biological: Placebo Sponsors: Valneva Austria GmbH; Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials